Clinical Trial Update: Preventing Inhibitor Recurrence Indefinitely [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on strategies to prevent inhibitor recurrence indefinitely in patients with Hemophilia A undergoing immune tolerance therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Children's Hospital Los Angeles | Conditions: Hemophilia A, Immune Tolerance | Phase 4 | Status: UNKNOWN